Simultaneous detection of tau phospho-epitopes with haptenylated antibodies

NeuroReport

Volumn 17, Issue 9, 2006, Pages 869-874

  Härtig, Wolfgang ^a   Lehmann, Jörg ^c   Stieler, Jens ^a   Singer, David ^a   Grosche, Jens ^a,b   Arendt, Thomas ^a   Hoffmann, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Thermo Integral GmbH and Co KG   (Germany)

Author keywords

Alzheimer's disease; Anti digoxin; Anti fluorescein; Carbocyanine; Digoxigenin anti digoxigenin; Hapten anti hapten technique; Neocortex; Tau pathology; Triple immunofluorescence labelling

Indexed keywords

CARBOCYANINE; DIGOXIGENIN; EPITOPE; FLUORESCEIN; HAPTEN ANTIBODY; MONOCLONAL ANTIBODY; PHOSPHOSERINE; PHOSPHOTHREONINE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIBODY LABELING; ANTIGEN DETECTION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NEOCORTEX; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOCORTEX; NERVE TISSUE PROTEINS; PHOSPHORYLATION; SERINE; TAU PROTEINS; THREONINE;

EID: 33745019110     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000215778.76602.da     Document Type: Article

References (25)

1. Lee VM-Y, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24:1121-1129.
2. Lovestone S, Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997; 78:309-324.
3. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-259.
4. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189:167-170.
5. Biernat J, Mandelkow E-M, Schröter C, Lichtenberg-Kraag B, Steiner B, Berling B, et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 1992; 11:1593-1597.
6. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994; 87:554-567.
7. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994; 301:871-877.
8. Hoffmann R, Lee VM-Y, Leight S, Varga I, Otvos L Jr. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Biochemistry 1997; 36:8114-8124.
9. Zheng-Fischhöfer Q, Biernat J, Mandelkow E-M, Illenberger S, Godemann R, Mandelkow E. Sequential phosphorylation of tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation. Eur J Biochem 1998; 252:542-552.
10. Augustinack JC, Schneider A, Mandelkow E-M, Hyman BT. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 2002; 103:26-35.
11. Van der Loos CM, Das PK, Van den Oord JJ, Houthoff HJ. Multiple immunofluorescence staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods 1989; 117:45-52.
12. Selkoe DJ. Alzheimer's disease: genes, proteins and therapy. Phys Rev 2001; 81:741-766.
13. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative disorders. Brain Res Rev 1995; 21:195-218.
14. Härtig W, Hausen D, Brauer K, Arendt T, Bigl V, Brückner G. Digoxigenin-tagged anti-GFAP and multiple labelling of human glia, vessels and β-amyloid. NeuroReport 1994; 5:573-576.
15. Härtig W, Kirazov L, Brückner G, Holzer M, Gärtner U, Bigl V. Blot analyses and immunocytochemistry of neural antigens with digoxigenylated primary and secondary antibodies. Brain Res Prot 1997; 2:35-43.
16. Davis JM, Pennington JE, Kubler AM, Conscience JK. A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies. J Immunol Methods 1982; 50:161-171.
17. Goding JW. Conjugation of antibodies with fluorochromes: modification to the standard methods. J Immunol Methods 1976; 13:215-226.
18. Härtig W, Brückner G, Holzer M, Brauer K, Bigl V. Digoxigenylated primary antibodies for sensitive dual-peroxidase labelling of neuronal markers. Histochem Cell Biol 1995; 104:467-472.
19. Schnell SA, Staines WA, Wessendorf MW. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999; 47:719-730.
20. Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005; 1739:179-197.
21. Miyasaka T, Watanabe A, Saito Y, Murayama S, Mann DMA, Yamazaki M, et al. Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads. J Neuropathol Exp Neurol 2005; 64:665-674.
22. Brandt R, Hundelt M, Shahani N. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 2005; 1739:331-354.
23. Härtig W, Klein C, Brauer K, Schüppel K-F, Arendt T, Brückner G, et al. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol 2000; 100:305-312.
24. Arendt T, Stieler J, Strijkstra AM, Hut RA, Rüdiger J, Van der Zee EA, et al. Reversible paired helical filament-like phosphorylation is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 2003; 18:6972-6981.
25. LaFerla FM, Oddo S. Alzheimer's disease: Aβ, tau and synaptic dysfunction. Trends Mol Med 2005; 11:170-176.